Literature DB >> 26714521

Putative hormone with anti-obesogenic and insulin-sensitizing effect.

Ivan Sosa1, Aron Grubesic2.   

Abstract

It was confirmed that bone morphogenetic protein-9 (BMP-9), like insulin, improves glycemia in diabetic mice and regulates glucose metabolism in hepatocytes, which is why it is proposed as a candidate for the hepatic insulin-sensitizing substance (HISS). Regarding the fact that BMP-9 has a signaling pathway similar to other BMPs as well as insulin, it is expected that BMP-9 would also have certain effects on the liver. In our 2011 hypothesis, we aimed towards BMP-9 as a possible "hepatic insulin-sensitizing substance" (HISS) and in this article, we provide further evidence, derived from existing studies, suggesting that this putative hormone might in fact be none other than BMP-9.
© The Author(s) 2015.

Entities:  

Keywords:  BMP-9; NO; endothelium

Mesh:

Substances:

Year:  2015        PMID: 26714521      PMCID: PMC5806741          DOI: 10.1177/0394632015623796

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  9 in total

Review 1.  The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes.

Authors:  W W Lautt
Journal:  Can J Physiol Pharmacol       Date:  1999-08       Impact factor: 2.273

2.  An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis.

Authors:  Cecil Chen; Krzysztof J Grzegorzewski; Steve Barash; Qinghai Zhao; Helmut Schneider; Qi Wang; Mallika Singh; Laurie Pukac; Adam C Bell; Roxanne Duan; Tim Coleman; Alokesh Duttaroy; Susan Cheng; Jon Hirsch; Linyi Zhang; Yanick Lazard; Carrie Fischer; Melisa Carey Barber; Zhi-Dong Ma; Ya-Qin Zhang; Peter Reavey; Lilin Zhong; Baiqin Teng; Indra Sanyal; Steve M Ruben; Olivier Blondel; Charles E Birse
Journal:  Nat Biotechnol       Date:  2003-02-24       Impact factor: 54.908

3.  Modulation of bone morphogenetic protein-9 expression and processing by insulin, glucose, and glucocorticoids: possible candidate for hepatic insulin-sensitizing substance.

Authors:  Luciana Chagas Caperuto; Gabriel Forato Anhê; Tavane David Cambiaghi; Eliana Hiromi Akamine; Daniella do Carmo Buonfiglio; José Cipolla-Neto; Rui Curi; Silvana Bordin
Journal:  Endocrinology       Date:  2008-08-14       Impact factor: 4.736

Review 4.  TGF-beta and the Smad signal transduction pathway.

Authors:  Arun Mehra; Jeffrey L Wrana
Journal:  Biochem Cell Biol       Date:  2002       Impact factor: 3.626

5.  HISS-dependent insulin resistance (HDIR) in aged rats is associated with adiposity, progresses to syndrome X, and is attenuated by a unique antioxidant cocktail.

Authors:  W Wayne Lautt; Zhi Ming; M Paula Macedo; Dallas J Legare
Journal:  Exp Gerontol       Date:  2008-04-27       Impact factor: 4.032

6.  Glucose-regulated insulin production in hepatocytes.

Authors:  Tausif Alam; Hans W Sollinger
Journal:  Transplantation       Date:  2002-12-27       Impact factor: 4.939

Review 7.  Regulation of obesity and insulin resistance by nitric oxide.

Authors:  Brian E Sansbury; Bradford G Hill
Journal:  Free Radic Biol Med       Date:  2014-05-28       Impact factor: 7.376

8.  Bone morphogenetic protein-9 is a circulating vascular quiescence factor.

Authors:  Laurent David; Christine Mallet; Michelle Keramidas; Noël Lamandé; Jean-Marie Gasc; Sophie Dupuis-Girod; Henri Plauchu; Jean-Jacques Feige; Sabine Bailly
Journal:  Circ Res       Date:  2008-02-28       Impact factor: 17.367

9.  Hepatoregenerative role of bone morphogenetic protein-9.

Authors:  Ivan Sosa; Olga Cvijanovic; Tanja Celic; Drazen Cuculic; Zeljka Crncevic-Orlic; Lucian Vukelic; Sanja Zoricic Cvek; Luka Dudaric; Alan Bosnar; Dragica Bobinac
Journal:  Med Sci Monit       Date:  2011-12
  9 in total
  1 in total

Review 1.  Potential Functions of the BMP Family in Bone, Obesity, and Glucose Metabolism.

Authors:  Yao Chen; Bingwei Ma; Xingchun Wang; Xiaojuan Zha; Chunjun Sheng; Peng Yang; Shen Qu
Journal:  J Diabetes Res       Date:  2021-06-23       Impact factor: 4.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.